Pathstone Family Office’s GeneDx Holdings WGS Stock Holding History

Pathstone Family Office’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$198K	Buy	54,327 +39,327	+262%	+$216K	﹤0.01%	1525
2023 Q2	$89.4K	Buy	+15,000	New	+$119K	﹤0.01%	1196

Other funds holding WGS

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Pathstone Family Office's WGS Position: Q3 2023 in Review

Pathstone Family Office increased its GeneDx Holdings (WGS) stake by 262% in Q3 2023, buying an estimated $216K and bringing the position to 54,327 shares worth $198K. The position accounts for ﹤0.01% of the portfolio, ranked #1525.

Pathstone Family Office first reported a position in WGS in Q2 2023 and has held it in 2 quarters since. 53 funds tracked by Wall St. Rank hold WGS as of Q3 2023.

Pathstone Family Office held 54,327 shares of GeneDx Holdings worth $198K as of Q3 2023.
Pathstone Family Office bought 39,327 GeneDx Holdings shares in Q3 2023, an estimated $216K.
GeneDx Holdings made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1525 holding.
Pathstone Family Office first reported a position in GeneDx Holdings in Q2 2023 and has held it in 2 quarters since.
53 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.